RESUMEN
Interleukin 37 (IL-37) is an anti-inflammatory cytokine expressed in foam cells located in the atherosclerosis plaques. The present study aimed to evaluate the association of the IL-37 polymorphisms with premature coronary artery disease (pCAD), cardiovascular risk factors, metabolic parameters, and levels of liver enzymes. Three IL-37 polymorphisms (rs6717710, rs2708961, and rs2708947) were determined in 1161 patients with pCAD and 951 healthy controls. IL-37 polymorphisms were not associated with the presence of pCAD. The association of the polymorphisms with cardiovascular risk factors, metabolic parameters, and levels of liver enzymes was evaluated independently in pCAD and healthy controls. In pCAD patients, under different models, the rs6717710 was associated with low risk of having elevated alkaline phosphatase (ALP) (padditive = 0.020; pdominant = 0.02; pheterozygous = 0.04; pcodominant1 = 0.040). On the other hand, in healthy controls, the rs6717710 was associated with low risk of having elevated levels of alanine aminotransferase (ALT) (padditive = 0.04, precessive = 0.01, pcodominant2 = 0.01) and aspartate aminotransferase (AST) (padditive = 0.02, pdominant = 0.02). The IL-37 polymorphisms were not associated with the risk of pCAD. In pCAD patients, the rs6717710 was associated with low risk of having elevated ALP levels, whereas in controls was associated with low risk of having elevated ALT and AST levels.
RESUMEN
OBJECTIVE: Identify and characterise the food industry's involvement in nutrition and dietetics national and regional events in Latin America and the Caribbean. DESIGN: Between February and April 2020, we conducted desk-based searches for nutrition and dietetics events held in the region between January 2018 and December 2019. Online freely accessible, publicly available information was collected on the involvement of the food industry through: sponsorship of events; sponsorship of sessions; speakers from the food industry; scholarships, fellowship, grants, awards and other prizes and; exhibition space/booths. SETTING: Nutrition and dietetics events in Latin America and the Caribbean. RESULTS: Thirty-one events held in twenty countries of the region had information publicly available online at the period of data collection. There was a lack of transparency on the involvement of industry actors in these events. When information was publicly available, we found that a total of ninety-two food industry actors sponsored 88 % of these events. CONCLUSIONS: There is a mostly unreported, but likely extensive, involvement of food industry actors in nutrition and dietetics events in Latin America and the Caribbean.
Asunto(s)
Industria de Alimentos , Industria de Procesamiento de Alimentos , Región del Caribe , Humanos , América Latina , Estado NutricionalRESUMEN
Interleukin 37 (IL-37) is an anti-inflammatory cytokine involved in the regulation of cholesterol homeostasis, reducing the levels of plasma cholesterol, fatty acids, and triglycerides. The aim of the present study was to evaluate the association of the IL-37 polymorphisms with the presence of hypercholesterolemia (HC), and with cardiovascular risk factors. Nine IL-37 polymorphisms (rs2708965, rs2708962, rs6717710, rs2708961, rs2708960, rs2708958, rs2723187, rs2708947, and rs2723192) were determined by TaqMan assays in a group of 1292 individuals (514 with and 778 without hypercholesterolemia) belonging to the cohort of the GEA Mexican Study. The associations were evaluated by logistic regression, using inheritance models adjusted by confounding variables. Under codominant 1 model, the rs2708961 (OR = 0.51, p = 0.02), rs2723187 (OR = 0.35, p = 0.005), and rs2708947 (OR = 0.49, p = 0.02) polymorphisms were associated with low risk of HC. The association of the polymorphisms with cardiovascular risk factors was evaluated independently in HC and non-HC individuals. In non-HC individuals, some polymorphisms were associated with the risk of having high levels of LDL-C, glucose, and high risk of T2DM, and low risk of having high visceral abdominal fat. On the other hand, in individuals with HC five, polymorphisms were associated with high levels of C-reactive protein. The IL-37 rs2708961, rs2723187, rs2708947 polymorphisms were associated with low risk of HC, and some IL-37 polymorphisms were associated with cardiometabolic factors in both individuals with and without HC.
Asunto(s)
Enfermedades Cardiovasculares/genética , Hipercolesterolemia/genética , Interleucina-1/genética , Modelos Genéticos , Polimorfismo Genético , Adulto , Femenino , Humanos , Masculino , México , Persona de Mediana Edad , Factores de RiesgoRESUMEN
INTRODUCTION: the restriction of nocturnal sleep has immediate effects, including the presence of excessive daytime sleepiness, general fatigue, or impaired concentration. In the long term, it increases the risk of death from cardiac, respiratory, and metabolic disorders, and the prevalence of obesity in healthy populations. However, despite the existence of a large number of studies on this topic, results have been controversial. OBJECTIVE: to discuss and analyze the evidence on the effects of nocturnal sleep restriction versus habitual sleep on dietary energy intake, including specific meals, as well as the relationship between ghrelin and leptin levels in a healthy population. METHODS: a systematic search of the literature was conducted in October 2016 and February 2019 using the PubMed, Scopus, Lilacs, and Embase databases. Terms used were "sleep," "feeding behavior," "dietary energy intake," "energy intake," "meal," "ghrelin," and "leptin." RESULTS: the bibliographic search identified 384 potential articles. Of a total of eight articles accepted in the review, six contain information available for the analysis of total energy intake. The overall result shows a significant difference in energy intake between study groups (149.86 (95 % CI: 10.09-289.63); p = 0.04), and a higher intake of all macronutrients. CONCLUSIONS: the present systematic review and meta-analysis demonstrated that partial sleep deprivation increases total energy intake, as well as all macronutrients, when compared to habitual sleep
INTRODUCCIÓN: la restricción del sueño nocturno tiene efectos inmediatos, como la presencia de somnolencia diurna excesiva, fatiga general o alteraciones en la concentración; a largo plazo, aumenta el riesgo de muerte por trastornos cardíacos, respiratorios y metabólicos, y aumenta la prevalencia de la obesidad en las poblaciones sanas. Sin embargo, a pesar de la existencia de una gran cantidad de estudios, los resultados siguen siendo controvertidos. OBJETIVO: discutir y analizar la evidencia sobre la restricción parcial del sueño frente al sueño habitual y su efecto en la ingesta dietética de energía, incluyendo comidas específicas, así como en las concentraciones de ghrelina y leptina en una población sana. MÉTODOS: se realizó una búsqueda electrónica de la literatura entre octubre de 2016 y febrero de 2019 en PubMed, Scopus, Lilacs y Embase. Los términos utilizados fueron "sleep", "feeding behavior", "dietary energy intake", "energy intake", "meal", "ghrelin" y "leptin". RESULTADOS: la búsqueda bibliográfica identificó 384 artículos potenciales. De un total de 8 artículos aceptados en la revisión, 6 tenían información disponible para el análisis de la ingesta total de energía. El resultado general mostró una diferencia significativa en la ingesta de energía (149,86 (IC 95 %: 10,09-289,63); p = 0,04) y una mayor ingesta de todos los macronutrientes. CONCLUSIONES: la presente revisión sistemática y meta-análisis indicó que la restricción del sueño aumenta la ingesta total de energía, así como la de todos los macronutrientes, en comparación con el sueño habitual
Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto Joven , Adulto , Persona de Mediana Edad , Metabolismo Energético , Privación de Sueño/fisiopatología , Ingestión de Energía , Privación de Sueño/metabolismo , Sueño/fisiología , Ghrelina/uso terapéutico , Leptina/uso terapéutico , Nutrientes/uso terapéuticoRESUMEN
INTRODUCTION: Background: the restriction of nocturnal sleep has immediate effects, including the presence of excessive daytime sleepiness, general fatigue, or impaired concentration. In the long term, it increases the risk of death from cardiac, respiratory, and metabolic disorders, and the prevalence of obesity in healthy populations. However, despite the existence of a large number of studies on this topic, results have been controversial. Objective: to discuss and analyze the evidence on the effects of nocturnal sleep restriction versus habitual sleep on dietary energy intake, including specific meals, as well as the relationship between ghrelin and leptin levels in a healthy population. Methods: a systematic search of the literature was conducted in October 2016 and February 2019 using the PubMed, Scopus, Lilacs, and Embase databases. Terms used were "sleep," "feeding behavior," "dietary energy intake," "energy intake," "meal," "ghrelin," and "leptin." Results: the bibliographic search identified 384 potential articles. Of a total of eight articles accepted in the review, six contain information available for the analysis of total energy intake. The overall result shows a significant difference in energy intake between study groups (149.86 (95 % CI: 10.09-289.63); p = 0.04), and a higher intake of all macronutrients. Conclusions: the present systematic review and meta-analysis demonstrated that partial sleep deprivation increases total energy intake, as well as all macronutrients, when compared to habitual sleep.
INTRODUCCIÓN: Antecedentes: la restricción del sueño nocturno tiene efectos inmediatos, como la presencia de somnolencia diurna excesiva, fatiga general o alteraciones en la concentración; a largo plazo, aumenta el riesgo de muerte por trastornos cardíacos, respiratorios y metabólicos, y aumenta la prevalencia de la obesidad en las poblaciones sanas. Sin embargo, a pesar de la existencia de una gran cantidad de estudios, los resultados siguen siendo controvertidos. Objetivo: discutir y analizar la evidencia sobre la restricción parcial del sueño frente al sueño habitual y su efecto en la ingesta dietética de energía, incluyendo comidas específicas, así como en las concentraciones de ghrelina y leptina en una población sana. Métodos: se realizó una búsqueda electrónica de la literatura entre octubre de 2016 y febrero de 2019 en PubMed, Scopus, Lilacs y Embase. Los términos utilizados fueron "sleep", "feeding behavior", "dietary energy intake", "energy intake", "meal", "ghrelin" y "leptin". Resultados: la búsqueda bibliográfica identificó 384 artículos potenciales. De un total de 8 artículos aceptados en la revisión, 6 tenían información disponible para el análisis de la ingesta total de energía. El resultado general mostró una diferencia significativa en la ingesta de energía (149,86 (IC 95 %: 10,09-289,63); p = 0,04) y una mayor ingesta de todos los macronutrientes. Conclusiones: la presente revisión sistemática y meta-análisis indicó que la restricción del sueño aumenta la ingesta total de energía, así como la de todos los macronutrientes, en comparación con el sueño habitual.
Asunto(s)
Ingestión de Energía/fisiología , Privación de Sueño/metabolismo , Dieta , Humanos , NutrientesRESUMEN
INTRODUCTION AND OBJECTIVES: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome. Some dietary fatty acids have showed different bioactive functions in metabolic syndrome. The aim of this study is to determine the dietary consumption patterns and serum percentage of bioactive fatty acids in NAFLD patients. PATIENTS AND METHODS: Cross-sectional study with NAFLD patients and non-NAFLD patients. Dietary consumption of bioactive fatty acids was assessed by a food frequency questionnaire. NAFLD and liver fibrosis were diagnosed by transient elastography. The identification of serum bioactive fatty acids was achieved by gas chromatography-mass spectrometry (%). Bioactive fatty acids consumption was correlated with NAFLD clinical characteristics with the Spearman correlation analysis. RESULTS: A total of 299 patients were included, whose mean of age and body mass index were 44.2±9.9 years and 25.9±3.8kg/m2, respectively. The consumption of bioactive fatty acids was no different regarding the presence of NAFLD; however, the consumption of stearic and linoleic fatty acids was higher in relation with NAFLD severity (p≤0.05). The consumption of myristic acid was higher in patients with fibrosis (p=0.02). Serum percentage and dietary consumption did not show correlations. CONCLUSION: Dietary consumption of bioactive fatty acids is different according to NAFLD severity. Individualized diets according to NAFLD severity could be successful in order to prevent liver injury-related outcomes.
Asunto(s)
Grasas de la Dieta/sangre , Ácidos Grasos/sangre , Cirrosis Hepática/sangre , Enfermedad del Hígado Graso no Alcohólico/sangre , Adulto , Estudios de Casos y Controles , Estudios Transversales , Registros de Dieta , Grasas de la Dieta/efectos adversos , Diagnóstico por Imagen de Elasticidad , Ácidos Grasos/efectos adversos , Femenino , Cromatografía de Gases y Espectrometría de Masas , Humanos , Cirrosis Hepática/diagnóstico por imagen , Cirrosis Hepática/etiología , Masculino , Persona de Mediana Edad , Enfermedad del Hígado Graso no Alcohólico/diagnóstico por imagen , Enfermedad del Hígado Graso no Alcohólico/etiología , Valor Nutritivo , Índice de Severidad de la EnfermedadRESUMEN
The participation of ubiquitin-conjugating enzyme E2Z (UBE2Z) in atherosclerosis has been reported. We aimed to evaluate the association of the rs46522 polymorphism of the UBE2Z gene with myocardial infarction (MI) and other clinical and metabolic components in the Mexican population. A total of 2128 individuals (1023 patients with MI and 1105 healthy controls) were included. rs46522 was genotyped using the 5' exonuclease TaqMan genotyping assay. A similar polymorphism distribution was observed between patients and healthy controls. The association between rs46522 polymorphism and cardiometabolic parameters was evaluated separately in the two groups. In the control group, rs46522 polymorphism was associated with increased risk of developing low-density lipoprotein cholesterol ≥130 mg/dL (odds ratio [OR] = 1.249, padditive = 0.018; OR = 1.479, precessive = 0.015; OR = 1.589, pcodominant 2 = 0.013). On the other hand, in MI patients, it was observed that rs46522 polymorphism was associated with an increased risk of developing high levels of alanine transaminase (OR = 1.297, pheterozygote = 0.043) and aspartate transaminase (OR = 1.453, pdominant = 0.009; OR = 1.592, pheterozygote = 0.001; OR = 1.632, pcodominant 1 = 0.001). Our results suggest that the UBE2Z gene rs46522 polymorphism is associated with abnormal metabolic parameters in Mexican patients with MI.
Asunto(s)
Aterosclerosis/genética , Infarto del Miocardio/genética , Infarto del Miocardio/metabolismo , Polimorfismo de Nucleótido Simple , Enzimas Ubiquitina-Conjugadoras/genética , Estudios de Casos y Controles , Estudios de Cohortes , Femenino , Humanos , Masculino , México/epidemiología , Persona de Mediana Edad , Infarto del Miocardio/epidemiologíaRESUMEN
Objective: Identify and characterise the food industry's involvement in nutrition and dietetics national and regional events in Latin America and the Caribbean. Design: Between February and April 2020, we conducted desk-based searches for nutrition and dietetics events held in the region between January 2018 and December 2019. Online freely accessible, publicly available information was collected on the involvement of the food industry through: sponsorship of events; sponsorship of sessions; speakers from the food industry; scholarships, fellowship, grants, awards and other prizes and; exhibition space/booths. Setting: Nutrition and dietetics events in Latin America and the Caribbean. Results: Thirty-one events held in twenty countries of the region had information publicly available online at the period of data collection. There was a lack of transparency on the involvement of industry actors in these events. When information was publicly available, we found that a total of ninety-two food industry actors sponsored 88 % of these events. Conclusions: There is a mostly unreported, but likely extensive, involvement of food industry actors in nutrition and dietetics events in Latin America and the Caribbean.(AU)
Asunto(s)
Industria de Alimentos/tendencias , Educación en Salud , Conferencias de Salud/tendencias , Nutrición, Alimentación y Dieta , Región del Caribe , Informe de Investigación , América LatinaRESUMEN
La crisis por COVID-19 (SARS-CoV-2) puede convertirse en una catástrofe alimentaria para Latinoamérica, aumentando las personas que padecen hambre de 135 a 265 millones, especialmente en Venezuela, Guatemala, Honduras, Haití y El Salvador, que ya enfrentaban crisis económicas y sanitarias. Este manuscrito presenta la posición de un grupo de expertos latinoamericanos sobre las recomendaciones de consumo y/o suplementación con vitamina A, C, D, zinc, hierro, folatos y micronutrientes múltiples, en contextos de desnutrición, para grupos vulnerables: mujeres embarazadas y lactantes, niñas y niños menores de 5 años y adultos mayores. Las recomendaciones buscan disminuir el impacto potencial que tendrá COVID-19 en el estado nutricional, durante la pandemia. La posición surge de la discusión de dichos expertos con base a la revisión de evidencia científica actual para estos grupos vulnerables. Está dirigida a tomadores de decisiones, encargados de políticas públicas, personal de salud y organismos de la sociedad civil. Después de la lactancia materna y una dieta suficiente en cantidad y calidad, la suplementación con los micronutrientes presentados, puede contribuir a prevenir y tratar enfermedades virales, reforzar el sistema inmune y reducir complicaciones. La lactancia materna con medidas de higiene respiratoria, el suministro de múltiples micronutrientes en polvo para niños desde los 6 meses hasta los 5 años y el aporte de hierro y folatos o micronutrientes múltiples para la embarazada, son estrategias comprobadas y eficaces que deben seguirse implementando en tiempos de COVID-19. Para los adultos mayores la suplementación con vitamina C, D y zinc puede estar indicada(AU)
The COVID-19 crisis (SARS-CoV-2) might transform into a food catastrophe in Latin America and would increase the number of people suffering from hunger from 135 to 265 million, particularly in Venezuela, Guatemala, Honduras, Haiti and El Salvador, already facing economic and health crises. This manuscript presents the position of a group of Latin American experts in nutrition for establishing the recommendations for consumption and / or supplementation with vitamin A, C, D, zinc, iron, folates and multiple micronutrients, in undernutrition contexts, for vulnerable population of pregnant and lactating women, children under 5 years and the elderly. The recommendations seek to decrease the potential impact that COVID-19 will have on nutritional status during the pandemic. The position arises from the discussion of the experts based on the review of current scientific evidence for these vulnerable groups. It aims to reach stakeholders, public policy makers, health personnel and civil society organizations. Only after breastfeeding and a sufficient diet in terms of quantity and quality, a supplementation with the micronutrients mentioned above can help prevent and treat viral diseases, strengthen the immune system and even reduce complications. Breastfeeding with respiratory hygiene measures, the provision of multiple micronutrients powders for children from 6 moths to 5 years of age and the supply of iron and folates or multiple micronutrients tablets for pregnant women are proven and effective strategies that must continue to be implemented during COVID-19 pandemic. For older adults, supplementation with vitamin C, D and zinc might be indicated(AU)
Asunto(s)
Humanos , Masculino , Femenino , Embarazo , Recién Nacido , Lactante , Preescolar , Niño , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Infecciones del Sistema Respiratorio , Nutrición de los Grupos Vulnerables , Hambre , Micronutrientes , COVID-19/epidemiología , Sistema Inmunológico , Avitaminosis , Suplementos Dietéticos , Enfermedades Carenciales , Desnutrición , Pandemias , América LatinaRESUMEN
Our previous data suggest that the heterodimeric interleukin-27 (IL-27) could participate in the developing of insulin resistance (IR). Our aim was to assess the participation of IL-27p28 gene single nucleotide polymorphisms (SNPs) as markers for IR, subclinical atherosclerosis (SA) and cardiovascular risk factors in a Mexican population. Five IL-27p28 SNPs (rs153109, rs40837, rs17855750, rs26528 and rs181206) were genotyped in 856 individuals with IR and 644 participants without IR. Under inheritance models adjusted for confounding factors, the rs153109A (0.78[0.64-0.94] Padditiveâ¯=â¯0.008, 0.58[0.41-0.82] Precessiveâ¯=â¯0.002, 0.57[0.38-0.83] Pcodominant2â¯=â¯0.004), rs26528T (0.78[0.64-0.94] Padditiveâ¯=â¯0.008, 0.61[0.43-0.88] Precessiveâ¯=â¯0.007, 0.57[0.38-0.84] Pcodominant2â¯=â¯0.004) and rs40837A (0.76[0.63-0.92] Padditiveâ¯=â¯0.004; 0.60[0.42-0.86] Precessiveâ¯=â¯0.005; 0.54[0.37-0.80] Pcodominant2â¯=â¯0.002) alleles were related with a decreased risk of IR. Moreover, AAATA haplotype that contains the protector alleles was related with 17% lower risk of presenting IR (0.83 [0.71-0.98], Pâ¯=â¯0.023). After adjusting for potential confounding variables, IL-27p28 SNPs were not associated with SA. However, some SNPs were associated with hypertension (rs26528 and rs40837) and increased total abdominal fat (rs17855750) in non-IR individuals, whereas in IR subjects we observed an association of rs26528 and rs40837 with hypoadiponectinemia. Our evidence suggests that rs40837A, rs153109A, and rs26528T alleles could be envisaged as protective markers for IR. Some polymorphisms showed an association with hypertension, low adiponectin levels, and increased total abdominal fat.
Asunto(s)
Aterosclerosis/genética , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Resistencia a la Insulina/genética , Interleucina-27/genética , Polimorfismo de Nucleótido Simple/genética , Femenino , Haplotipos/genética , Humanos , Masculino , México , Persona de Mediana Edad , Factores de RiesgoRESUMEN
INTRODUCTION AND AIM: Association of vitamin D deficiency (VDD) with fatty liver (FL) disease is controversial. The purpose of this study was to analyze the association of VDD with FL. MATERIAL AND METHODS: Cross-sectional study. Data on cardiovascular risk factors, medications, alcohol intake, smoking, diet, and physical activity were obtained. Biochemical, anthropometric, and blood pressure variables were measured. The 25-hydroxyvitamin D (25(OH)D) was quantified through chemoluminescence. The presence of FL, defined as a liver/spleen attenuation index lower than 1.0, was identified through computed axial tomography (CAT). RESULTS: The study included 1,467 subjects (49.7% men) with a mean age of 53.3 ± 9.3 years and BMI of 28.3 ± 4.0 kg/m2. Only 11% had optimum values of vitamin D, and 25(OH)D concentration was lower in participants with FL. Multivariate logistic regression models, adjusted for age, gender, BMI, sampling season, glucose, total cholesterol, triglycerides, HOMA-IR, hs-CRP, ALT, AST, and elevated VAT, revealed an association between FL and vitamin D (VD) insufficiency (RM 1.61 [0.99-2.61]) and with VDD (RM 1.68 [1.02-2.77]); however, statistical significance was lost when including caloric consumption and physical activity in the model. CONCLUSIONS: In Mexican adults, deficient VD concentration and FL were not independently associated of caloric consumption and physical activity.
Asunto(s)
Hígado Graso/epidemiología , Deficiencia de Vitamina D/epidemiología , Adulto , Biomarcadores/sangre , Estudios Transversales , Ingestión de Energía , Ejercicio Físico , Hígado Graso/diagnóstico por imagen , Femenino , Humanos , Masculino , México/epidemiología , Persona de Mediana Edad , Factores de Riesgo , Tomografía Computarizada por Rayos X , Vitamina D/análogos & derivados , Vitamina D/sangre , Deficiencia de Vitamina D/sangre , Deficiencia de Vitamina D/diagnósticoRESUMEN
Several studies have reported the role of hedgehog interacting protein-like 1 (HHIPL-1) in different pathologies, including cardiovascular disease. The aim of the present study was to analyze the association of HHIPL-1 (rs2895811) polymorphism with myocardial infarction (MI), cardiometabolic parameters, and traditional cardiovascular risk factors in the Mexican population. The polymorphism was genotyped using a TaqMan assay in 1023 patients with MI and 1105 controls. A similar distribution of the polymorphism was observed between studied groups. However, in patients group, the C allele was associated with a decreased risk of developing hypertriglyceridemia (ORâ¯=â¯0.757, Padditiveâ¯=â¯0.030, ORâ¯=â¯0.685, Pdominantâ¯=â¯0.020, ORâ¯=â¯0.691, Pcodominant1â¯=â¯0.030), metabolic syndrome (ORâ¯=â¯0.746, Padditiveâ¯=â¯0.030, ORâ¯=â¯0.647, Pdominantâ¯=â¯0.005, ORâ¯=â¯0.670, Pheterozygoteâ¯=â¯0.015, ORâ¯=â¯0.637, Pcodominant1â¯=â¯0.005), and insulin resistance (ORâ¯=â¯0.681, Pdominantâ¯=â¯0.045). The results suggest that HHIPL-1 rs2895811 polymorphism is associated with cardiometabolic parameters in Mexican patients with MI.
Asunto(s)
Hipertrigliceridemia/genética , Resistencia a la Insulina/genética , Péptidos y Proteínas de Señalización Intercelular/genética , Síndrome Metabólico/genética , Infarto del Miocardio/genética , Polimorfismo de Nucleótido Simple , Adulto , Femenino , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Masculino , México , Persona de Mediana Edad , Factores de RiesgoRESUMEN
Interleukin 10 (IL-10) is an anti-inflammatory cytokine with a protective role in the formation and the development of the atherosclerotic plaque. The aim of the present study was to establish if IL-10 gene polymorphisms are associated with the development of premature coronary artery disease (pCAD) and cardiovascular risk factors in Mexican individuals. Three IL-10 gene polymorphisms [-592C/A (rs1800872), -819C/T (rs1800871), and -1082 A/G (rs1800896)] and IL-10 plasma levels were analyzed in 2266 individuals (1160 pCAD patients and 1106 healthy controls). Under recessive and co-dominant2 models, the -1082 A/G (rs1800896) G allele was associated with decreased risk of developing pCAD (ORâ¯=â¯0.572, Precâ¯=â¯0.022 and ORâ¯=â¯0.567, Pcod2â¯=â¯0.023). In pCAD patients, the polymorphisms were associated with hyperinsulinemia, small and dense LDLs, hypertension, and diabetes mellitus. In the control group, the polymorphisms were associated with hypertension, hyperuricemia, and small and dense LDLs. pCAD patients have significantly higher IL-10 plasma levels than healthy controls [0.91 (0.55-1.67) pg/mL vs 0.45 (0.24-0.98) pg/mL, respectively, Pâ¯<â¯0.0001]. Nevertheless, these levels were not associated with the genotypes analyzed in the present study. The results suggest that the IL-10-1082 A/G (rs1800896) G allele is associated with a decreased risk of developing pCAD. In patients and controls, the polymorphisms analyzed were associated with some cardiovascular risk factors. Although, in pCAD patients the IL-10 plasma levels were higher, they were not associated with the genotypes of the polymorphisms examined.
Asunto(s)
Alelos , Enfermedad de la Arteria Coronaria/genética , Enfermedad de la Arteria Coronaria/metabolismo , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Interleucina-10/genética , Polimorfismo de Nucleótido Simple/genética , Estudios de Casos y Controles , Enfermedad de la Arteria Coronaria/sangre , Enfermedad de la Arteria Coronaria/epidemiología , Femenino , Humanos , Interleucina-10/sangre , Masculino , Persona de Mediana Edad , Prevalencia , Factores de RiesgoRESUMEN
The phosphodiesterase family is involved in a wide spectrum of diseases, including ischemic stroke. However, few studies have analyzed the relationship between phosphodiesterase 4D (PDE4D) and myocardial infarction (MI). Therefore, the aim of this research was to evaluate the association of the PDE4D gene polymorphisms with MI, and with cardiometabolic parameters in the Mexican population. Six polymorphisms (rs2910829, rs1423246, rs966221, rs4502776, rs13172481, and rs6869495) were genotyped in 1023 MI patients and 1105 healthy controls. A similar distribution of the six polymorphisms was observed in both studied groups. However, after evaluating the linkage disequilibrium, we detected a risk haplotype for MI (AGAGAA; OR = 1.148; P = 0.025). In addition, the polymorphisms were associated with the presence of some clinical and metabolic parameters (central obesity, hypertriglyceridemia, Aspartate transaminase >p75, Lipoprotein (a) >30 mg/dL, TAT >p75, fatty liver, and vitamin D <30 ng/dL) in healthy controls. The results suggest that in the Mexican population, a PDE4D haplotype is associated with increased risk of developing MI, and that PDE4D polymorphisms are independently associated with the presence of cardiometabolic parameters.
RESUMEN
Resumen: Objetivo: La prevalencia de calcificación arterial coronaria (CAC), marcador específico de aterosclerosis, no es conocida en México. Nuestro objetivo fue investigar la prevalencia y extensión de CAC y su asociación con factores de riesgo cardiovascular en población mexicana. Métodos: La CAC fue medida por tomografía computarizada multidetector en individuos asintomáticos que participaron en el estudio Genética de la Enfermedad Aterosclerosa. Los factores de riesgo cardiovascular y los medicamentos fueron registrados. Resultados: La muestra incluyó 1,423 individuos (49.5% hombres), con una edad de 53.7 ± 8.4 años. Los portadores de CAC mostraron prevalencias más altas de dislipidemia, diabetes, hipertensión y otros factores de riesgo. La prevalencia de CAC > 0 unidades Agatston fue de 27%, significativamente más alta en hombres (40%) que en mujeres (13%). Los valores medios del puntaje de CAC aumentaron consistentemente con la edad y fueron más altos en hombres que en mujeres en todos los grupos etarios. La edad y el c-LDL elevado se asociaron de manera independiente con la prevalencia de CAC > 0 en hombres y mujeres, mientras que la presión arterial sistólica en las mujeres, y el incremento de la edad en ambos géneros mostró una asociación independiente con la severidad de CAC. Conclusiones: En población mexicana la prevalencia y la extensión de CAC fueron mucho más altas en hombres que en mujeres y aumentaron consistentemente con la edad. Los predictores independientes de la prevalencia de CAC fueron la edad y el c-LDL.
Abstract: Objective: The prevalence of coronary artery calcification (CAC), a specific marker of atherosclerosis, is unknown in Mexico. Our aim was to investigate the prevalence and quantity of CAC and their association with cardiovascular risk factors in a Mexican population. Methods: CAC was measured by multidetector computed tomography in asymptomatic subjects who participated in the Genetics of Atherosclerotic Disease study. Cardiovascular risk factors and medication were recorded. Results: The sample included 1,423 individuals (49.5% men), aged 53.7 ± 8.4 years. Those with CAC showed a higher prevalence of dyslipidaemia, diabetes, hypertension, and other risk factors. The prevalence of CAC > 0 Agatston units was significantly higher among men (40%) than among women (13%). Mean values of CAC score increased consistently with increasing age and were higher in men than women in each age group. Age and high low density lipoprotein cholesterol were independently associated with prevalence of CAC > 0 in men and women, while increasing systolic blood pressure in women and age in both genders showed an independent association with CAC extension. Conclusions: In the Mexican population the prevalence and extent of CAC were much higher in men than in women, and strongly increased with age. Independent predictors of CAC prevalence were age and low density lipoprotein cholesterol (LDL-C).
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Anciano , Enfermedad de la Arteria Coronaria/epidemiología , Calcificación Vascular/epidemiología , Enfermedad de la Arteria Coronaria/etiología , Enfermedades Cardiovasculares/complicaciones , Prevalencia , Estudios Transversales , Factores de Riesgo , Enfermedades Asintomáticas , Calcificación Vascular/etiología , México/epidemiologíaRESUMEN
Objective: To investigate the independent association between vitamin D deficiency (VDD) and coronary artery disease (CAD) in Mexican adult population. Method: Matched case-control study. Data cardiovascular on risk factors, medication use, physical activity, alcohol use, smoking and vitamin D consumption were obtained. Biochemical variables, anthropometric and blood pressure were measured. 25(OH)D was quantified by chemiluminescence. Results: We studied 250 patients with established CAD and 250 age-gender-body mass index (BMI) matched control subjects, with a mean age of 53 ± 6.1 years and BMI of 28 ± 3.5 kg/m2. Deficiency of 25(OH)D was significantly higher in the control group (21.2 vs. 16%). Multiple logistic regression analysis did not show association between VDD and CAD (OR: 1.37 [0.08-23.2]). Multiple linear regression analysis also showed that statin use (b = 2.2; p = 0.004) and no alcohol use (b = -1.8; p = 0.03) significantly increased 25(OH)D levels. Conclusions: No independent association between VDD and the presence of coronary artery disease was found in Mexican adult population. The results suggest that treatment with statins and absence of alcohol consumption, might be the explanation for the higher concentrations of 25(OH)D observed in patients with CAD.
Asunto(s)
Consumo de Bebidas Alcohólicas/epidemiología , Enfermedad de la Arteria Coronaria/epidemiología , Inhibidores de Hidroximetilglutaril-CoA Reductasas/administración & dosificación , Deficiencia de Vitamina D/epidemiología , Adulto , Anciano , Índice de Masa Corporal , Estudios de Casos y Controles , Enfermedad de la Arteria Coronaria/etiología , Enfermedad de la Arteria Coronaria/genética , Femenino , Humanos , Modelos Lineales , Masculino , México/epidemiología , Persona de Mediana Edad , Factores de Riesgo , Deficiencia de Vitamina D/etiologíaRESUMEN
Interleukin 35 (IL-35) is a heterodimeric cytokine involved in the development of atherosclerosis. The aim of the present study was to establish if the polymorphisms of IL-12A and EBI3 genes that encode the IL-35 subunits are associated with the development of premature coronary artery disease (CAD) in Mexican individuals. The IL-12A and EBI3 polymorphisms were determined in 1162 patients with premature CAD and 873 controls. Under different models, the EBI3 rs428253 (OR = 0.831, Padd = 0.036; OR = 0.614, Prec = 0.033; OR = 0.591, Pcod2 = 0.027) and IL-12A rs2243115 (OR = 0.674, Padd = 0.010; OR = 0.676, Pdom = 0.014; OR = 0.698, Phet = 0.027; OR = 0.694, Pcod1 = 0.024) polymorphisms were associated with decreased risk of developing premature CAD. Some polymorphisms were associated with clinical and metabolic parameters. Significant different levels of IL-35 were observed in EBI3 rs4740 and rs4905 genotypes only in the group of healthy controls. In summary, our study suggests that the EBI3 and IL-12A polymorphisms play an important role in decreasing the risk of developing premature CAD; it also demonstrates the relationship of the EBI3 rs4740 and rs4905 genotypes with IL-35 levels in healthy individuals.
Asunto(s)
Enfermedad de la Arteria Coronaria/genética , Enfermedad de la Arteria Coronaria/metabolismo , Interleucinas/genética , Interleucinas/metabolismo , Polimorfismo de Nucleótido Simple/genética , Adulto , Aterosclerosis/genética , Aterosclerosis/metabolismo , Femenino , Frecuencia de los Genes/genética , Predisposición Genética a la Enfermedad/genética , Genotipo , Haplotipos/genética , Humanos , Masculino , Persona de Mediana Edad , Factores de RiesgoRESUMEN
OBJECTIVE: The prevalence of coronary artery calcification (CAC), a specific marker of atherosclerosis, is unknown in Mexico. Our aim was to investigate the prevalence and quantity of CAC and their association with cardiovascular risk factors in a Mexican population. METHODS: CAC was measured by multidetector computed tomography in asymptomatic subjects who participated in the Genetics of Atherosclerotic Disease study. Cardiovascular risk factors and medication were recorded. RESULTS: The sample included 1,423 individuals (49.5% men), aged 53.7±8.4 years. Those with CAC showed a higher prevalence of dyslipidaemia, diabetes, hypertension, and other risk factors. The prevalence of CAC>0 Agatston units was significantly higher among men (40%) than among women (13%). Mean values of CAC score increased consistently with increasing age and were higher in men than women in each age group. Age and high low density lipoprotein cholesterol were independently associated with prevalence of CAC>0 in men and women, while increasing systolic blood pressure in women and age in both genders showed an independent association with CAC extension. CONCLUSIONS: In the Mexican population the prevalence and extent of CAC were much higher in men than in women, and strongly increased with age. Independent predictors of CAC prevalence were age and low density lipoprotein cholesterol (LDL-C).
Asunto(s)
Enfermedad de la Arteria Coronaria/epidemiología , Calcificación Vascular/epidemiología , Adulto , Anciano , Enfermedades Asintomáticas , Enfermedades Cardiovasculares/complicaciones , Enfermedad de la Arteria Coronaria/etiología , Estudios Transversales , Femenino , Humanos , Masculino , México/epidemiología , Persona de Mediana Edad , Prevalencia , Factores de Riesgo , Calcificación Vascular/etiologíaRESUMEN
The receptor-interacting protein 2 (Rip2) is a serine/threonine kinase involved in multiple nuclear factor-κB (NFκB) activation pathways and is a key regulator of cellular lipid metabolism and cardiovascular disease. The aim of the present study was to evaluate the role of RIP2 gene polymorphisms as susceptibility markers for subclinical atherosclerosis (SA). Using an informatics analysis, four RIP2 gene polymorphisms with predicted functional effects (rs2293808, rs43133, rs431264, and rs16900627) were selected. The polymorphisms were genotyped in 405 individuals with SA (calcium score>0 assessed by computed tomography) and 1099 controls (calcium score=0). Clinical, anthropometric, tomographic and biochemical traits were measured. The association between the RIP2 polymorphisms and SA was evaluated using logistic regression analyses. Pair wise linkage disequilibrium (LD, D') estimations between polymorphisms and haplotype reconstruction were performed with Haploview version 4:1. Under different models adjusted by age, gender, body mass index, hypertension, diabetes mellitus, smoking habit, total cholesterol, HDL-cholesterol, LDL-cholesterol and triglyceride levels, rs43133 (OR=1.43, 95% CI: 1.05-1.94, P=0.022), and rs16900627 (OR=1.59, 95% CI: 1.00-2.54, Pdom=0.048 and OR=1.60, 95% CI: 1.05-2.54, Padd=0.028) were associated with increased risk of developing SA. Moreover, rs2293808, and rs431264 were associated with clinical or metabolic parameters in SA individuals and in healthy controls. The four polymorphisms were in high linkage disequilibrium and the GAAG haplotype was associated with increased risk of developing SA (OR=1.47, P=0.027). This study shows for the first time, that RIP2 polymorphisms are associated with increased risk of SA and with some clinical and metabolic parameters.